Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Nuo Therapeutics, Inc. (AURX)

Income Statement Business | Product | Geographic

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-15Dec-31-14Dec-31-13
   10-K10-K10-K10-K10-K10-K10-K10-K
Revenues   [+]0.00.00.11.40.711.57.811.6
            Revenue growth   -100.0%-89.3%90.1% 48.3%-32.9%9.5%
Cost of goods sold   [+]0.00.00.10.22.98.06.88.5
Gross profit  0.00.00.01.2-2.23.51.03.1
            Gross margin    21.6%88.1%-304.0%30.8%12.8%26.9%
Selling, general and administrative   [+]0.10.40.82.14.515.315.715.3
Research and development    0.20.61.32.64.03.8
Other operating expenses      -1.80.00.12.1
EBITDA   [+]  -0.9-1.4-5.1-13.5-18.2-17.0
            EBITDA margin    -601.6%-102.3%-710.2%-117.5%-234.8%-146.9%
Depreciation    0.10.10.30.70.61.1
EBITA  -0.1-0.4-1.0-1.5-5.4-14.3-18.8-18.1
            EBITA margin    -663.0%-109.8%-746.6%-124.0%-242.7%-156.4%
Amortization of intangibles      0.9   
EBIT   [+]-0.1-0.4-1.0-1.5-6.2-14.3-18.8-18.1
            EBIT margin    -663.0%-109.8%-864.7%-124.0%-242.7%-156.4%
Non-recurring items   [+]    9.327.04.6 
Interest expense, net   [+] 0.00.20.00.039.31.70.6
Other income (expense), net   [+] 0.30.00.00.627.76.2-1.6
Pre-tax income  -0.1-0.1-1.2-1.5-15.0-52.9-18.9-20.2
Income taxes  0.00.00.00.00.0-0.10.00.0
            Tax rate  0.0%0.0%0.0%0.0%0.0%0.2%  
Net income  -0.1-0.1-1.2-1.5-15.0-52.8-18.9-20.2
            Net margin    -817.4%-112.5%-2077.4%-458.8%-243.3%-175.0%
   
Basic EPS   [+]$0.00$0.00($0.05)($0.07)($1.02)($0.42)($0.16)($0.20)
Diluted EPS   [+]$0.00$0.00($0.05)($0.07)($1.02)($0.42)($0.16)($0.20)
   
   
Shares outstanding (basic)   [+]30.325.723.723.314.6126.0120.5103.6
Shares outstanding (diluted)   [+]30.327.323.723.314.6126.0120.5103.6
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy